Abstract 13350: Improvement of Left Ventricular Diastolic Property is a Crucial Factor for Benefits from Cardiac Resynchronization Therapy
M Maeda, Masafumi Kitakaze(Hanwa Memorial Hospital), Hideaki Kanzaki(National Cerebral and Cardiovascular Center), Masanori Asakura(National Cerebral and Cardiovascular Center), Makoto Amaki(National Cerebral and Cardiovascular Center), Hiroyuki Takahama(Tohoku University), Takuya Hasegawa(National Cerebral and Cardiovascular Center), Akira Funada(National Cerebral and Cardiovascular Center)
Circulation
November 23, 2010
Cited by 0
Related Papers
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: Metalloproteinase inhibitors as a new therapy
|Nature Medicine|2002|722
Right Ventricular Function in Heart Failure With Preserved Ejection Fraction
|Circulation|2014|456
JCS/JSCS/JATS/JSVS 2020 Guidelines on the Management of Valvular Heart Disease
|Circulation Journal|2020|363
Metformin Prevents Progression of Heart Failure in Dogs
|Circulation|2009|288